|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | |
| A61P 7/12 | |||
| A61P 9/00 | |||
| A61P 43/00 |
| (11) | Patento numeris | 3169325 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15822307.3 |
| Europos patento paraiškos padavimo data | 2015-07-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/040659 |
| Data | 2015-07-15 |
| (87) | Numeris | WO 2016/011209 |
| Data | 2016-01-21 |
| (30) | Numeris | Data | Šalis |
| 201462025203 P | 2014-07-16 | US | |
| PCT/US2014/0728 | 2014-12-30 | WO | |
| 201562187786 P | 2015-07-01 | US | |
| 201562190223 P | 2015-07-08 | US |
| (72) |
MCDONALD, Andrew, US
QIAN, Shawn, US
|
| (73) |
Attune Pharmaceuticals, Inc.,
250 W. 55th Street, 34th Floor,, New York, NY 10019,
US
|
| (54) | THERAPEUTIC INHIBITORY COMPOUNDS |
| THERAPEUTIC INHIBITORY COMPOUNDS |